Validation of Completion of Items 18, 19 and 22 of the Motor Function Measure (MFM) on a Digital Tablet

NCT03465358 | Completed

• 1 other identifier: 69HCL17_0851
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 5

Brief Summary

Motor Function Measure (MFM) is a validated tool assessing the motor function of neuromuscular patients constituted of 32 items. Despite standardized Motor Function Measure (MFM) training sessions, there is still an inter-individual variability in the items' scoring procedure, depending for example on the subjectivity of the therapist. Among the 32 items of the MFM, 3 currently require the use of a paper, and could be automated by using a digital tablet. It is the item 18 where the patient traces the edge of a Compact Disc, item 19 requiring to draw loops inside a frame and item 22 requiring to place a finger on each standardized cases. The reproducibility of these 3 items could be improved with the use of a digital tablet and the development of a software allowing to computerize the scoring procedure. The second interest is to implement directly the MFM data in the MFM base. The hypothesis is that the difference of scoring of these 3 items between digital tablet versus paper completion is enough low to use indifferently each completion in patients with a neuromuscular disease.

Conditions

Neuromuscular Diseases

Outcome Measures

Primary Outcomes (1)

• Comparison scoring between items completed using conventional material or on a digital tablet.

  The comparison of scores between usual test (paper) versus digital tablet test, for the item 18, 19 and 22 of the Motor Function Measure.

  1 day

Interventions

Items completion OTHER

Patients will complete his Motor Function Measure in the usual way, except items 18, 19 and 22 which will be completed twice: once using conventional material and once on a digital tablet. The order of completion between conventional material or digital tablet will be allocate randomly.

Eligibility Criteria

• Age: 5 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Patients with neuromuscular disease

You may qualify if:

• Patients with a labelled neuromuscular disease
• Patients with Motor Function Measure in one of the participating services during their usual follow-up
• Patients who received the information and did not object to participating in the study or their parents for the children

You may not qualify if:

• Patients passing their Motor Function Measure as part of another research protocol

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (5)

Service de Rééducation Fonctionnelle Pédiatrique - L'Escale (Aile A1) - Hôpital Femme Mère Enfant - GHE

Bron, 69677, France

Location

Centre de référence MNM Adulte Grenoble Consultation Maladies Neuromusculaires Adultes - CHU Michallon

Grenoble, 38043, France

Location

Centre de référence MNM adulte Lyon Hôpital de la Croix Rousse Bâtiment P

Lyon, 69317, France

Location

Service de Médecine Physique et de Réadaptation Pédiatrique Hôpital de Bellevue, CHU

Saint-Etienne, 42055, France

Location

Centre de référence MNM Adulte Saint Etienne CHU Hôpital Nord-service neurologie

Saint-Priest-en-Jarez, 42270, France

Location

MeSH Terms

Conditions

Neuromuscular Diseases

Condition Hierarchy (Ancestors)

Nervous System Diseases

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 8, 2018
• First Posted: March 14, 2018
• Study Start: March 14, 2018
• Primary Completion: November 28, 2018
• Study Completion: November 28, 2018
• Last Updated: August 14, 2019

Record last verified: 2019-08

Data Sharing

• IPD Sharing: Will not share

Locations

FR (5)